« go back

GlycoMar Limited and MicroA AS launch new company specialising in production of polysaccharides from microalgae

Scottish biotechnology company GlycoMar and Norwegian technology company MicroA have announced a new joint venture business, called Prasinotech Ltd. The new company is registered in Scotland.

Prasinotech is the first company in the world specialising in the production of polysaccharides from microalgae. The products will have applications in healthcare, cosmetics, and nutrition.

These products were discovered by GlycoMar and developed through pilot production at MicroA. Prasinotech will implement industrial scale cultivation and processing of microalgae at facilities in Norway, which utilise MicroA’s unique photobioreactor technology.

Prasinotech’s first products are Prasinoguard and PrasinoPS, active ingredients for use in cosmetic skincare. These products are projected to have an annual value of US$ 2 million in the third year in production.

Prasinotech takes its name from the microalga Prasinococcus capsulatus, a marine species producing a valuable polysaccharide discovered by GlycoMar.

Production of the polysaccharide is sustainable and completely natural using only light and CO2 to cultivate the microalga in seawater. The polysaccharide is purified by advanced processing techniques developed with grant support from Innovate UK, Innovation Norway, and the Industrial Biotechnology Innovation Centre.

GlycoMar Limited, based at the European Centre for Marine Biotechnology, near Oban (Scotland) is a specialist biotechnology company discovering and developing new therapeutic products from marine resources. The company is developing anti-inflammatory products with applications in nutrition, cosmetics, and pharmaceuticals.

GlycoMar’s founder, Dr Charlie Bavington, said “we are delighted that our close collaboration with MicroA has progressed to a joint venture. We are confident that Glycomar and MicroA have developed technology that will make Prasinotech a success.”

MicroA AS, based in Stavanger (Norway) is a biotechnology company specialising in the production of high value products from microalgae. The company has developed a patented photobioreactor system which enables high efficiency production of the nutraceutical astaxanthin and polysaccharide products now being manufactured by Prasinotech.

MicroA’s founder, Svein Dahle said “We are very happy to have this joint venture with GlycoMar. The two companies work well together and have created excellent technology which will make Prasinotech a commercial success”.


For more information on MicroA visit

For further information on GlycoMar visit


Story source: MicroA press release, 11 Jan 2016

No comments yet. Be the first.

Webinar on funding opportunities for Industrial Biotech & SynBio

This KTN webinar provided an update on the upcoming funding opportunities for industrial biotechnology & synthetic biology, with particular focus on the remit of each competition and where applications are likely to fit best. 

Download the slide deck >>

Watch the webinar recording >>

Subscribe to our updates

Subscribe to our newsletters
Follow us on twitter

Join us on LinkedIn

Keep up to date with the latest agri-food and biosciences news, events, funding opportunities and more.

Got a Question?


Email us Email Us
Contact a member of our team